Exact Mass: 504.1419

Exact Mass Matches: 504.1419

Found 13 metabolites which its exact mass value is equals to given mass value 504.1419, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Bequinostatin A

Bequinostatin A

C28H24O9 (504.142)


   

4-Ac,1,2,3-tribenzoyl-alpha-D-Pyranose-Arabinose|alpha-D-Pyranose-Arabinose

4-Ac,1,2,3-tribenzoyl-alpha-D-Pyranose-Arabinose|alpha-D-Pyranose-Arabinose

C28H24O9 (504.142)


   

b-D-Ribofuranose 1-acetate 2,3,5-tribenzoate

b-D-Ribofuranose 1-acetate 2,3,5-tribenzoate

C28H24O9 (504.142)


   

alpha-D-Ribofuranose 1-acetate 2,3,5-tribenzoate

alpha-D-Ribofuranose 1-acetate 2,3,5-tribenzoate

C28H24O9 (504.142)


   

1-acetyl-2,3,5-tri-o-benzoyl-b-l-ribofuranose

1-acetyl-2,3,5-tri-o-benzoyl-b-l-ribofuranose

C28H24O9 (504.142)


   

[(2R,3R,4R)-5-acetyloxy-3,4-dibenzoyloxyoxolan-2-yl]methyl benzoate

[(2R,3R,4R)-5-acetyloxy-3,4-dibenzoyloxyoxolan-2-yl]methyl benzoate

C28H24O9 (504.142)


   

Vofopitant (dihydrochloride)

Vofopitant (dihydrochloride)

C21H25Cl2F3N6O (504.1419)


Vofopitant dihydrochloride (GR 205171A) is a potent, selective and orally available tachykinin neurokinin 1(NK1) receptor antagonist, inhibits [3H]SP binding to the NK1 receptor with pKi values of 9.5 and 10.6 in rat and human membranes respectively, acts as a potential broad-spectrum anti-emetic agent[1].

   

3,9-bis(3,4-dihydroxyphenyl)-2,13,15-trihydroxy-4-oxatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-5,11,13,15-tetraen-7-one

3,9-bis(3,4-dihydroxyphenyl)-2,13,15-trihydroxy-4-oxatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-5,11,13,15-tetraen-7-one

C28H24O9 (504.142)


   

5,11,13,17,19-pentahydroxy-15,22-dioxo-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(14),2,4(9),5,7,12,16,18,20-nonaene-6-carboxylic acid

5,11,13,17,19-pentahydroxy-15,22-dioxo-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(14),2,4(9),5,7,12,16,18,20-nonaene-6-carboxylic acid

C28H24O9 (504.142)


   

(1s,2s,3r,9r,10s)-3,9-bis(3,4-dihydroxyphenyl)-2,13,15-trihydroxy-4-oxatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-5,11,13,15-tetraen-7-one

(1s,2s,3r,9r,10s)-3,9-bis(3,4-dihydroxyphenyl)-2,13,15-trihydroxy-4-oxatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-5,11,13,15-tetraen-7-one

C28H24O9 (504.142)


   

(1s,2s,3r,9r,10s,17s)-3,9-bis(3,4-dihydroxyphenyl)-2,13,15-trihydroxy-4-oxatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-5,11,13,15-tetraen-7-one

(1s,2s,3r,9r,10s,17s)-3,9-bis(3,4-dihydroxyphenyl)-2,13,15-trihydroxy-4-oxatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-5,11,13,15-tetraen-7-one

C28H24O9 (504.142)


   

(11r)-5,11,13,17,19-pentahydroxy-15,22-dioxo-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(14),2,4(9),5,7,12,16,18,20-nonaene-6-carboxylic acid

(11r)-5,11,13,17,19-pentahydroxy-15,22-dioxo-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(14),2,4(9),5,7,12,16,18,20-nonaene-6-carboxylic acid

C28H24O9 (504.142)